XBI SPDR SERIES TRUST
FollowS&P BIOTECH (fund)
809 managers (818 13F filers) reported a position in XBI shares at 2025-12-31, 134,682,882 shares in all. 188 filers opened a position and 51 filers sold out during the quarter.
- Managers
- 809
- 13F filers
- 818
- New
- 188
- Added
- 233
- Reduced
- 205
- Sold out
- 51
- Shares held by filers
- 134,682,882
Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q4 2025
Filers in the available 13F reports with a share position at 2025-12-31, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Grey Ledge Advisors, LLC | 7 | $854 | <0.01% | 0 | 13F-HRTimeline |
| 1620 INVESTMENT ADVISORS, INC. | 7 | $854 | <0.01% | 0 | 13F-HRTimeline |
| Cape Investment Advisory, Inc. | 7 | $854 | <0.01% | new | 13F-HRTimeline |
| Quattro Advisors LLC | 6 | $737 | <0.01% | 13F-HRTimeline | |
| Bogart Wealth, LLC | 6 | $735 | <0.01% | 0 | 13F-HRTimeline |
| Goodman Advisory Group, LLC | 6 | $732 | <0.01% | 0 | 13F-HRTimeline |
| Horizon Investments, LLC | 2 | $244 | <0.01% | 0 | 13F-HRTimeline |
| Parallax Volatility Advisers, L.P. | 1 | $122 | <0.01% | -194,819 | 13F-HRTimeline |
| Camelot Portfolios, LLC | 0 | $8 | <0.01% | new | 13F-HRTimelineAmount filed as zero, left out of ratios. |